$CTRE
CareTrust REIT, Inc. Stock $ctre

$ctre Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000162828023027216 Filed on August 03, 2023

Income Statement

Concept	2023 Q3	2023 Q2
Revenue	$55.88M	$51.55M
YoY Change	11.1%	8.41%
Cost Of Revenue	$1.240M	$658.0K
YoY Change	-67.44%	639.33%
Gross Profit	$54.64M	$50.90M
YoY Change	17.54%	7.23%
Gross Profit Margin	97.79%	98.72%
Selling, General & Admin	$7.690M	$6.108M
YoY Change	31.45%	-1.99%
% of Gross Profit	14.07%	12.0%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$13.00M	$12.73M
YoY Change	5.95%	1.26%
% of Gross Profit	23.79%	25.01%
Operating Expenses	$20.72M	$18.82M
YoY Change	14.44%	0.18%
Operating Profit	$33.92M	$32.07M
YoY Change	19.53%	11.85%
Interest Expense	$11.75M	$11.04M
YoY Change	40.63%	75.15%
% of Operating Profit	34.64%	34.42%
Other Income/Expense, Net
YoY Change
Pretax Income	$8.690M	-$484.0K
YoY Change	1125.67%	-102.34%
Income Tax
% Of Pretax Income
Net Earnings	$8.696M	-$484.0K
YoY Change	1126.52%	-102.34%
Net Earnings / Revenue	15.56%	-0.94%
Basic Earnings Per Share	$0.08	-$0.01
Diluted Earnings Per Share	$0.08	-$0.01
COMMON SHARES
Basic Shares Outstanding	99.48M shares	99.48M shares
Diluted Shares Outstanding	104.3M shares	99.12M shares

Balance Sheet

Concept	2023 Q3	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.500M	$1.145M
YoY Change	-28.0%	-96.22%
Cash & Equivalents	$3.485M	$1.145M
Short-Term Investments
Other Short-Term Assets	$20.70M	$14.03M
YoY Change	8.68%	105.19%
Inventory
Prepaid Expenses
Receivables	$400.0K	$387.0K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$24.60M	$15.56M
YoY Change	-0.47%	-59.03%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.717B	$1.695B
YoY Change	11.3%	12.59%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$25.80M	$26.34M
YoY Change	-66.94%	-81.5%
Total Long-Term Assets	$1.743B	$1.721B
YoY Change	7.53%	4.47%
TOTAL ASSETS
Total Short-Term Assets	$24.60M	$15.56M
Total Long-Term Assets	$1.743B	$1.721B
Total Assets	$1.768B	$1.737B
YoY Change	7.41%	3.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$28.90M	$21.04M
YoY Change	-6.32%	-3.26%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$61.30M	$48.88M
YoY Change	6.28%	0.67%
LONG-TERM LIABILITIES
Long-Term Debt	$595.3M	$875.0M
YoY Change	-23.11%	9.53%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$595.3M	$875.0M
YoY Change	-23.11%	9.53%
TOTAL LIABILITIES
Total Short-Term Liabilities	$61.30M	$48.88M
Total Long-Term Liabilities	$595.3M	$875.0M
Total Liabilities	$656.6M	$923.9M
YoY Change	-21.07%	9.02%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$1.567B	$1.247B
YoY Change	30.87%	4.22%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.110B	$813.0M
YoY Change
Total Liabilities & Shareholders Equity	$1.768B	$1.737B
YoY Change	7.41%	3.04%

Cashflow Statement

Concept	2023 Q3	2023 Q2
OPERATING ACTIVITIES
Net Income	$8.696M	-$484.0K
YoY Change	1126.52%	-102.34%
Depreciation, Depletion And Amortization	$13.00M	$12.73M
YoY Change	5.95%	1.26%
Cash From Operating Activities	$45.10M	$31.87M
YoY Change	6.44%	-5.51%
INVESTING ACTIVITIES
Capital Expenditures	$28.90M	$176.8M
YoY Change	-1664.7%	-10440.0%
Acquisitions
YoY Change
Other Investing Activities	-$26.80M	$988.0K
YoY Change	87.83%	-100.99%
Cash From Investing Activities	-$55.70M	-$175.8M
YoY Change	245.64%	73.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	12.90M	117.0M
YoY Change	-124.97%	63.62%
NET CHANGE
Cash From Operating Activities	45.10M	31.87M
Cash From Investing Activities	-55.70M	-175.8M
Cash From Financing Activities	12.90M	117.0M
Net Change In Cash	2.300M	-26.93M
YoY Change	-109.05%	-831.46%
FREE CASH FLOW
Cash From Operating Activities	$45.10M	$31.87M
Capital Expenditures	$28.90M	$176.8M
Free Cash Flow	$16.20M	-$144.9M
YoY Change	-63.36%	-509.08%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	185767	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	20.94
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	61680	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	21.19
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1736952000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1620781000	usd
CY2023Q2	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	47745000	usd
CY2022Q2	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	46806000	usd
CY2023Q2	us-gaap	Revenues Revenues	51553000	usd
CY2022Q2	us-gaap	Revenues Revenues	47553000	usd
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	12716000	usd
CY2022Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	12559000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	11040000	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	6303000	usd
CY2023Q2	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	1390000	usd
CY2022Q2	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	1254000	usd
CY2023Q2	us-gaap	Impairment Losses Related To Real Estate Partnerships ImpairmentLossesRelatedToRealEstatePartnerships	21392000	usd
CY2022Q2	us-gaap	Impairment Losses Related To Real Estate Partnerships ImpairmentLossesRelatedToRealEstatePartnerships	1701000	usd
CY2023Q2	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	0	usd
CY2022Q2	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	0	usd
	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	0	usd
	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	3844000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-484000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	20669000	usd
	us-gaap	Net Income Loss NetIncomeLoss	18743000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-22595000	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.21
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.19
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.24
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.21
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.19
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.24
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	99117000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	96564000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	99090000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	96487000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	99117000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	96598000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	99194000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	96487000	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	849373000	usd
CY2023Q1	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-1479000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	936000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.28
CY2023Q1	us-gaap	Dividends Common Stock DividendsCommonStock	27738000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	19227000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	840319000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	924000	usd
CY2023Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.28
CY2023Q2	us-gaap	Dividends Common Stock DividendsCommonStock	27737000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-484000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	813022000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	915757000	usd
CY2022Q1	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-2772000	usd
CY2022Q1	us-gaap	Dividends Common Stock DividendsCommonStock	26659000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-43264000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	844583000	usd
CY2022Q2	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-1697000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1394000	usd
CY2022Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.275
CY2022Q2	us-gaap	Dividends Common Stock DividendsCommonStock	26681000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	20669000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	838268000	usd
	us-gaap	Net Income Loss NetIncomeLoss	18743000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-22595000	usd
	ctre	Depreciation And Amortization Including Below Market Ground Leases Excluding Amortization Of Deferred Financing Costs DepreciationAndAmortizationIncludingBelowMarketGroundLeasesExcludingAmortizationOfDeferredFinancingCosts	24983000	usd
	ctre	Depreciation And Amortization Including Below Market Ground Leases Excluding Amortization Of Deferred Financing Costs DepreciationAndAmortizationIncludingBelowMarketGroundLeasesExcludingAmortizationOfDeferredFinancingCosts	26167000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1217000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1040000	usd
	ctre	Unrealized Gain Loss On Other Real Estate Related Investments Operating Cash Flows UnrealizedGainLossOnOtherRealEstateRelatedInvestmentsOperatingCashFlows	-2605000	usd
	ctre	Unrealized Gain Loss On Other Real Estate Related Investments Operating Cash Flows UnrealizedGainLossOnOtherRealEstateRelatedInvestmentsOperatingCashFlows	0	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1860000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2915000	usd
	us-gaap	Straight Line Rent StraightLineRent	-14000	usd
	us-gaap	Straight Line Rent StraightLineRent	11000	usd
	us-gaap	Sales Type Lease Impairment Loss SalesTypeLeaseImpairmentLoss	0	usd
	us-gaap	Sales Type Lease Impairment Loss SalesTypeLeaseImpairmentLoss	977000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-184000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	13000	usd
	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	1958000	usd
	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	186000	usd
	us-gaap	Impairment Losses Related To Real Estate Partnerships ImpairmentLossesRelatedToRealEstatePartnerships	23278000	usd
	us-gaap	Impairment Losses Related To Real Estate Partnerships ImpairmentLossesRelatedToRealEstatePartnerships	61384000	usd
	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	0	usd
	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	3844000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-14000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-578000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	330000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1724000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3624000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-4074000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	66986000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	68302000	usd
	us-gaap	Payments To Acquire Commercial Real Estate PaymentsToAcquireCommercialRealEstate	172453000	usd
	us-gaap	Payments To Acquire Commercial Real Estate PaymentsToAcquireCommercialRealEstate	21915000	usd
	ctre	Payments To Acquire Equipment Furniture And Fixtures And Develop Real Estate Assets PaymentsToAcquireEquipmentFurnitureAndFixturesAndDevelopRealEstateAssets	6380000	usd
	ctre	Payments To Acquire Equipment Furniture And Fixtures And Develop Real Estate Assets PaymentsToAcquireEquipmentFurnitureAndFixturesAndDevelopRealEstateAssets	3628000	usd
	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	27262000	usd
	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	102086000	usd
	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	15287000	usd
	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	1026000	usd
	us-gaap	Payments For Deposits On Real Estate Acquisitions PaymentsForDepositsOnRealEstateAcquisitions	300000	usd
	us-gaap	Payments For Deposits On Real Estate Acquisitions PaymentsForDepositsOnRealEstateAcquisitions	0	usd
	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	14464000	usd
	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	959000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-176644000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-125644000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-629000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	155000000	usd
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	125000000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	21000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1479000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	4469000	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	55246000	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	52817000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	97625000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	67714000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-12033000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	10372000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13178000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19895000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1145000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	30267000	usd
	us-gaap	Interest Paid Net InterestPaidNet	21000000	usd
	us-gaap	Interest Paid Net InterestPaidNet	10987000	usd
	ctre	Increase Decrease In Dividends Payable IncreaseDecreaseInDividendsPayable	294000	usd
	ctre	Increase Decrease In Dividends Payable IncreaseDecreaseInDividendsPayable	522000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	369000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
	ctre	Transfer Of Preacquisition Costs To Acquired Assets TransferOfPreacquisitionCostsToAcquiredAssets	0	usd
	ctre	Transfer Of Preacquisition Costs To Acquired Assets TransferOfPreacquisitionCostsToAcquiredAssets	7000	usd
	us-gaap	Noncash Or Part Noncash Divestiture Amount Of Consideration Received1 NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1	2000000	usd
	us-gaap	Noncash Or Part Noncash Divestiture Amount Of Consideration Received1 NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1	0	usd
CY2023Q2	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	28	state
CY2023Q2	us-gaap	Real Estate Investments Joint Ventures RealEstateInvestmentsJointVentures	166800000	usd
CY2023Q2	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	47752000	usd
CY2022Q2	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	46801000	usd
CY2023Q2	us-gaap	Land Land	266010000	usd
CY2022Q4	us-gaap	Land Land	238738000	usd
CY2023Q2	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	1575661000	usd
CY2022Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	1483133000	usd
CY2023Q2	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	97755000	usd
CY2022Q4	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	97199000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2832000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2832000	usd
CY2023Q2	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	1942258000	usd
CY2022Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	1821902000	usd
CY2023Q2	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	414024000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	400492000	usd
CY2023Q2	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1528234000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1421410000	usd
CY2023Q2	us-gaap	Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear	98155000	usd
CY2023Q2	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	197155000	usd
CY2023Q2	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	198310000	usd
CY2023Q2	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	198853000	usd
CY2023Q2	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	195687000	usd
CY2023Q2	us-gaap	Lessor Operating Lease Payments To Be Received Five Years LessorOperatingLeasePaymentsToBeReceivedFiveYears	193433000	usd
CY2023Q2	us-gaap	Lessor Operating Lease Payments To Be Received Thereafter LessorOperatingLeasePaymentsToBeReceivedThereafter	941966000	usd
CY2023Q2	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	2023559000	usd
	ctre	Period Of Option Window PeriodOfOptionWindow	P6M
	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	93922000	usd
	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	93779000	usd
CY2023Q2	us-gaap	Straight Line Rent StraightLineRent	-7000	usd
CY2022Q2	us-gaap	Straight Line Rent StraightLineRent	5000	usd
	us-gaap	Straight Line Rent StraightLineRent	-14000	usd
	us-gaap	Straight Line Rent StraightLineRent	11000	usd
CY2023Q2	ctre	Operating Lease Lease Income Adjustments For Collectability OperatingLeaseLeaseIncomeAdjustmentsForCollectability	0	usd
CY2022Q2	ctre	Operating Lease Lease Income Adjustments For Collectability OperatingLeaseLeaseIncomeAdjustmentsForCollectability	0	usd
	ctre	Operating Lease Lease Income Adjustments For Collectability OperatingLeaseLeaseIncomeAdjustmentsForCollectability	0	usd
	ctre	Operating Lease Lease Income Adjustments For Collectability OperatingLeaseLeaseIncomeAdjustmentsForCollectability	977000	usd
CY2023Q2	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	47745000	usd
CY2022Q2	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	46806000	usd
	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	93908000	usd
	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	92813000	usd
CY2023Q2	ctre	Operating Leases Tenant Operating Expense Reimbursement OperatingLeasesTenantOperatingExpenseReimbursement	1200000	usd
CY2022Q2	ctre	Operating Leases Tenant Operating Expense Reimbursement OperatingLeasesTenantOperatingExpenseReimbursement	700000	usd
	ctre	Operating Leases Tenant Operating Expense Reimbursement OperatingLeasesTenantOperatingExpenseReimbursement	1900000	usd
	ctre	Operating Leases Tenant Operating Expense Reimbursement OperatingLeasesTenantOperatingExpenseReimbursement	1300000	usd
	ctre	Number Of Existing And Former Operators With Doubtful Collectability NumberOfExistingAndFormerOperatorsWithDoubtfulCollectability	4	operator
	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	172453000	usd
	ctre	Operating Leases Anticipated Initial Annual Lease Revenues OperatingLeasesAnticipatedInitialAnnualLeaseRevenues	14496000	usd
	ctre	Number Of Properties Acquired NumberOfPropertiesAcquired	12	property
	ctre	Number Of Beds Or Units In Properties Acquired NumberOfBedsOrUnitsInPropertiesAcquired	1280	bed
CY2023Q2	ctre	Financing Receivable Principal Amount FinancingReceivablePrincipalAmount	175143000	usd
CY2023Q2	us-gaap	Notes Receivable Gross NotesReceivableGross	166822000	usd
CY2022Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	156368000	usd
CY2023Q2	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	1	facility
	ctre	Loan Receivable Origination Fee LoanReceivableOriginationFee	1019000	usd
	ctre	Loan Receivable Origination Fee LoanReceivableOriginationFee	2500000	usd
	ctre	Financing Receivable Principal Payments Received FinancingReceivablePrincipalPaymentsReceived	287000	usd
	ctre	Financing Receivable Principal Payments Received FinancingReceivablePrincipalPaymentsReceived	276000	usd
	ctre	Loan Receivable Accrued Interest LoanReceivableAccruedInterest	-1000	usd
	ctre	Loan Receivable Accrued Interest LoanReceivableAccruedInterest	2000	usd
	ctre	Loan Receivable Provision For Loan Losses Net LoanReceivableProvisionForLoanLossesNet	0	usd
	ctre	Loan Receivable Provision For Loan Losses Net LoanReceivableProvisionForLoanLossesNet	4594000	usd
	ctre	Loan Receivable Net Change LoanReceivableNetChange	733000	usd
	ctre	Loan Receivable Net Change LoanReceivableNetChange	-2372000	usd
CY2023Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	3808000	usd
CY2022Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	747000	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	8251000	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	1216000	usd
CY2023Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	880000000	usd
CY2023Q2	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	4952000	usd
CY2023Q2	us-gaap	Long Term Debt LongTermDebt	875048000	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	725000000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	5502000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	719498000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.28
CY2023Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.28
CY2023Q1	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2023-04-14
CY2023Q2	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2023-07-14
CY2023Q1	us-gaap	Dividends Payable Current DividendsPayableCurrent	27846000	usd
CY2023Q2	us-gaap	Dividends Payable Current DividendsPayableCurrent	27853000	usd
CY2023Q1	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2023-03-31
CY2023Q2	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2023-06-30
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	573609	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	20.63
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	350930	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	20.28
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	924000	usd
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1394000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1860000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2915000	usd
	us-gaap	Stock Granted During Period Value Sharebased Compensation Forfeited StockGrantedDuringPeriodValueSharebasedCompensationForfeited	900000	usd
CY2023Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	7200000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-484000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	20669000	usd
	us-gaap	Net Income Loss NetIncomeLoss	18743000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-22595000	usd
CY2023Q2	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	89000	usd
CY2022Q2	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	94000	usd
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	178000	usd
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	211000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-573000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-573000	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	20575000	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	20575000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	18565000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	18565000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-22806000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-22806000	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	99117000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	96564000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	99090000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	96487000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	99117000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	96598000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	99194000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	96487000	shares
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.21
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.19
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.24
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.21
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.19
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.24
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	500000	shares
CY2022Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	341000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	316000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	431000	shares

Files In Submission

Name	View Source	Status
0001628280-23-027216-index-headers.html	Edgar Link	pending
0001628280-23-027216-index.html	Edgar Link	pending
0001628280-23-027216.txt	Edgar Link	pending
0001628280-23-027216-xbrl.zip	Edgar Link	pending
ctre-20230630.htm	Edgar Link	pending
ctre-20230630.xsd	Edgar Link	pending
ctre20230630q2ex311.htm	Edgar Link	pending
ctre20230630q2ex312.htm	Edgar Link	pending
ctre20230630q2ex321.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
ctre-20230630_def.xml	Edgar Link	unprocessable
ctre-20230630_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ctre-20230630_htm.xml	Edgar Link	completed
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ctre-20230630_cal.xml	Edgar Link	unprocessable
ctre-20230630_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CTRE
CareTrust REIT, Inc. Stock $ctre

2023 Q3 Form 10-Q Financial Statement

#000162828023027216 Filed on August 03, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CTRE CareTrust REIT, Inc. Stock $ctre

2023 Q3 Form 10-Q Financial Statement

#000162828023027216 Filed on August 03, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CTRE
CareTrust REIT, Inc. Stock $ctre